Minnesota Oncology

Cervical Cancer News

Gardasil Provides Poor Protection in Women Over 18 (February 3, 2014)

A significant percentage of women vaccinated with Gardasil® (quadrivalent human papillomavirus recombinant vaccine) may not be protected against high-grade squamous intraepithelial lesions (HSIL) and lesser dysplasia—especially if they were vaccinated... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (September 16, 2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive... Continue Reading

Younger Girls May Need Fewer Gardasil Shots (June 26, 2013)

Two doses of the human papillomavirus (HPV) vaccine Gardasil may be just as effective in younger girls (preteens) as the recommended three doses given to older teens, according to the results of a study published in the Journal of the American Medical... Continue Reading

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 11, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)

Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading

Gardasil is Safe, According to Large Study (October 12, 2012)

The HPV vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) was found to be safe, according to the results of a large safety study published in the Archives of Pediatrics & Adolescent Medicine. The study... Continue Reading

HPV Testing Can Predict Risk of Cervical Cancer for Up to 18 Years (August 8, 2012)

A test for the human papillomavirus (HPV) provides information about a woman’s long-term risk of cervical precancers, according to the results of a study published early online in the Journal of Clinical Oncology. Each year in the United States, there... Continue Reading

Latest Cervical Cancer News By Stage


Metastatic/Stage IVB Cervical Cancer

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 11, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading

More Metastatic/Stage IVB Cervical Cancer

Recurrent Cervical Cancer

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 11, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading

Avastin® Shows Promise in Treatment of Cervical Cancer (March 8, 2009)

Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment of persistent or recurrent squamous cell carcinoma... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

More Recurrent Cervical Cancer

Screening/Prevention Cervical Cancer

Gardasil Provides Poor Protection in Women Over 18 (February 3, 2014)

A significant percentage of women vaccinated with Gardasil® (quadrivalent human papillomavirus recombinant vaccine) may not be protected against high-grade squamous intraepithelial lesions (HSIL) and lesser dysplasia—especially if they were vaccinated... Continue Reading

Younger Girls May Need Fewer Gardasil Shots (June 26, 2013)

Two doses of the human papillomavirus (HPV) vaccine Gardasil may be just as effective in younger girls (preteens) as the recommended three doses given to older teens, according to the results of a study published in the Journal of the American Medical... Continue Reading

HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)

Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading

HPV Vaccination Does Not Lead to Increase in Sex (October 19, 2012)

Vaccination against the human papillomavirus (HPV) does not lead to increased sexual activity, according to the results of a study published in the journal Vaccine. HPV is the most common sexually transmitted infection in the United States. There are... Continue Reading

Gardasil is Safe, According to Large Study (October 12, 2012)

The HPV vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) was found to be safe, according to the results of a large safety study published in the Archives of Pediatrics & Adolescent Medicine. The study... Continue Reading

More Screening/Prevention Cervical Cancer

Stage I Cervical Cancer

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer (June 9, 2009)

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading

More Stage I Cervical Cancer

Stages II-IVA Cervical Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer (June 8, 2009)

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading

More Stages II-IVA Cervical Cancer